FOREFRONT ANALYTICS, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
FOREFRONT ANALYTICS, LLC portfolio value:
$216,000
portfolio value
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 315 shares | 216K | $688.87 | 315 |
| Q2 2022 | share | Decrease | -100.00% | -515 shares | -353K | $591.13 | 0 |
| Q1 2022 | share | Increase | +31.38% | 123 shares | 104K | $698.42 | 515 |
| Q4 2021 | share | Increase | +2.62% | 10 shares | 16K | $642.51 | 392 |
| Q3 2021 | share | Decrease | -9.48% | -40 shares | -2K | $605.18 | 382 |
| Q2 2021 | share | Decrease | -16.44% | -83 shares | -3K | $558.54 | 422 |
| Q1 2021 | share | Increase | 0.00% | 505 shares | 238K | $473.14 | 505 |